Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1271-1280 of 1,553) with videos related to

Pageof 156
Sort By:
Frontiers in Oncology|November 16, 2020
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal CancerTing Xu, Yinjie Zhang, Jing Zhang, et al.
Journal for Immunotherapy of Cancer|June 15, 2022
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancerZhenghang Wang, Qi Zhang, Changsong Qi, et al.
Journal of Cancer|April 30, 2019
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1<sup>st</sup>-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II StudyXiaodong Zhang, Jun Jia, Ming Lu, et al.
Future Oncology (London, England)|February 3, 2021
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinomaManish A Shah, Jaafar Bennouna, Toshihiko Doi, et al.
International Journal of Biological Macromolecules|February 2, 2023
Untargeted serum and liver metabolomics analyses reveal the gastroprotective effect of polysaccharide from Evodiae fructus on ethanol-induced gastric ulcer in miceJiang-Hong Luo, Wan-Shuang Zou, Jing Li, et al.
Journal of Hematology & Oncology|August 9, 2024
Recent developments in immunotherapy for gastrointestinal tract cancersXiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Materials Today. Bio|December 16, 2025
PUFAs-enriched oil bodies as natural anti-osteoarthritis drug delivery platformsLin Shen, Junyan Li, Xinyu Zhang, et al.
BMC Cancer|February 20, 2020
Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from ChinaRuihua Xu, Wei Wang, Bo Zhu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2015
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancerJinwan Wang, Ruihua Xu, Jian Li, et al.
Nature Communications|August 18, 2022
Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironmentYang Chen, Keren Jia, Yu Sun, et al.
Pageof 156

Showing results (1271-1280 of 1,553) with videos related to

Sort By:
Pageof 156
Frontiers in Oncology|November 16, 2020
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal CancerTing Xu, Yinjie Zhang, Jing Zhang, et al.
Journal for Immunotherapy of Cancer|June 15, 2022
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancerZhenghang Wang, Qi Zhang, Changsong Qi, et al.
Journal of Cancer|April 30, 2019
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1<sup>st</sup>-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II StudyXiaodong Zhang, Jun Jia, Ming Lu, et al.
Future Oncology (London, England)|February 3, 2021
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinomaManish A Shah, Jaafar Bennouna, Toshihiko Doi, et al.
International Journal of Biological Macromolecules|February 2, 2023
Untargeted serum and liver metabolomics analyses reveal the gastroprotective effect of polysaccharide from Evodiae fructus on ethanol-induced gastric ulcer in miceJiang-Hong Luo, Wan-Shuang Zou, Jing Li, et al.
Journal of Hematology & Oncology|August 9, 2024
Recent developments in immunotherapy for gastrointestinal tract cancersXiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Materials Today. Bio|December 16, 2025
PUFAs-enriched oil bodies as natural anti-osteoarthritis drug delivery platformsLin Shen, Junyan Li, Xinyu Zhang, et al.
BMC Cancer|February 20, 2020
Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from ChinaRuihua Xu, Wei Wang, Bo Zhu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2015
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancerJinwan Wang, Ruihua Xu, Jian Li, et al.
Nature Communications|August 18, 2022
Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironmentYang Chen, Keren Jia, Yu Sun, et al.
Pageof 156